153 related articles for article (PubMed ID: 36931033)
1. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways.
Granda-Díaz R; Manterola L; Hermida-Prado F; Rodríguez R; Santos L; García-de-la-Fuente V; Fernández MT; Corte-Torres MD; Rodrigo JP; Álvarez-Teijeiro S; Lawrie CH; Garcia-Pedrero JM
Biomed Pharmacother; 2023 May; 161():114512. PubMed ID: 36931033
[TBL] [Abstract][Full Text] [Related]
2. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2.
Li X; Zhao S; Fu Y; Zhang P; Zhang Z; Cheng J; Liu L; Jiang H
Int J Biol Sci; 2021; 17(15):4327-4339. PubMed ID: 34803501
[TBL] [Abstract][Full Text] [Related]
3. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
4. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
[TBL] [Abstract][Full Text] [Related]
5. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
Hou Y; Zhou M; Li Y; Tian T; Sun X; Chen M; Xu W; Lu M
Mol Carcinog; 2022 Aug; 61(8):797-811. PubMed ID: 35687049
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.
Ruicci KM; Plantinga P; Pinto N; Khan MI; Stecho W; Dhaliwal SS; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Nichols AC
Mol Oncol; 2019 Oct; 13(10):2160-2177. PubMed ID: 31393061
[TBL] [Abstract][Full Text] [Related]
7. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
[TBL] [Abstract][Full Text] [Related]
9. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
Ruicci KM; Pinto N; Khan MI; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
Oral Oncol; 2018 Sep; 84():95-103. PubMed ID: 30115483
[TBL] [Abstract][Full Text] [Related]
10. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.
Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q
Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
[TBL] [Abstract][Full Text] [Related]
12. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
14. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
Xue K; Li J; Nan S; Zhao X; Xu C
Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
[TBL] [Abstract][Full Text] [Related]
17. Impact of Oncogenic Targets by Tumor-Suppressive
Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
[TBL] [Abstract][Full Text] [Related]
18. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma.
Li J; Chen W; Luo L; Liao L; Deng X; Wang Y
Aging (Albany NY); 2020 Nov; 13(1):769-781. PubMed ID: 33257597
[TBL] [Abstract][Full Text] [Related]
19. Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma.
Saad MA; Kuo SZ; Rahimy E; Zou AE; Korrapati A; Rahimy M; Kim E; Zheng H; Yu MA; Wang-Rodriguez J; Ongkeko WM
Mol Cancer; 2015 Oct; 14():181. PubMed ID: 26472042
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
